457 related articles for article (PubMed ID: 30909497)
1. CD44s Assembles Hyaluronan Coat on Filopodia and Extracellular Vesicles and Induces Tumorigenicity of MKN74 Gastric Carcinoma Cells.
Härkönen K; Oikari S; Kyykallio H; Capra J; Hakkola S; Ketola K; Thanigai Arasu U; Daaboul G; Malloy A; Oliveira C; Jokelainen O; Sironen R; Hartikainen JM; Rilla K
Cells; 2019 Mar; 8(3):. PubMed ID: 30909497
[TBL] [Abstract][Full Text] [Related]
2. Human mesenchymal stem cells secrete hyaluronan-coated extracellular vesicles.
Arasu UT; Kärnä R; Härkönen K; Oikari S; Koistinen A; Kröger H; Qu C; Lammi MJ; Rilla K
Matrix Biol; 2017 Dec; 64():54-68. PubMed ID: 28483644
[TBL] [Abstract][Full Text] [Related]
3. CD44: structure, function, and association with the malignant process.
Naor D; Sionov RV; Ish-Shalom D
Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
[TBL] [Abstract][Full Text] [Related]
4. Interaction with hyaluronan matrix and miRNA cargo as contributors for in vitro potential of mesenchymal stem cell-derived extracellular vesicles in a model of human osteoarthritic synoviocytes.
Ragni E; Perucca Orfei C; De Luca P; Lugano G; Viganò M; Colombini A; Valli F; Zacchetti D; Bollati V; de Girolamo L
Stem Cell Res Ther; 2019 Mar; 10(1):109. PubMed ID: 30922413
[TBL] [Abstract][Full Text] [Related]
5. Temporal variation in the distribution of hyaluronic acid, CD44s, and CD44v6 in the human endometrium across the menstrual cycle.
Afify AM; Craig S; Paulino AF
Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):328-33. PubMed ID: 16932025
[TBL] [Abstract][Full Text] [Related]
6. EMT induced by EGF and wounding activates hyaluronan synthesis machinery and EV shedding in rat primary mesothelial cells.
Koistinen V; Härkönen K; Kärnä R; Arasu UT; Oikari S; Rilla K
Matrix Biol; 2017 Nov; 63():38-54. PubMed ID: 28043889
[TBL] [Abstract][Full Text] [Related]
7. Molecular weight specific impact of soluble and immobilized hyaluronan on CD44 expressing melanoma cells in 3D collagen matrices.
Sapudom J; Ullm F; Martin S; Kalbitzer L; Naab J; Möller S; Schnabelrauch M; Anderegg U; Schmidt S; Pompe T
Acta Biomater; 2017 Mar; 50():259-270. PubMed ID: 27965172
[TBL] [Abstract][Full Text] [Related]
8. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
Afify A; Purnell P; Nguyen L
Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells.
Twarock S; Tammi MI; Savani RC; Fischer JW
J Biol Chem; 2010 Jul; 285(30):23276-84. PubMed ID: 20463012
[TBL] [Abstract][Full Text] [Related]
10. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion.
Bourguignon LY; Singleton PA; Diedrich F; Stern R; Gilad E
J Biol Chem; 2004 Jun; 279(26):26991-7007. PubMed ID: 15090545
[TBL] [Abstract][Full Text] [Related]
11. CD44 loss in gastric stromal tumors as a prognostic marker.
Montgomery E; Abraham SC; Fisher C; Deasel MR; Amr SS; Sheikh SS; House M; Lilliemoe K; Choti M; Brock M; Ephron DT; Zahuruk M; Chadburn A
Am J Surg Pathol; 2004 Feb; 28(2):168-77. PubMed ID: 15043305
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the Efficiency of Hyaluronic Acid for Tumor Targeting via CD44.
Spadea A; Rios de la Rosa JM; Tirella A; Ashford MB; Williams KJ; Stratford IJ; Tirelli N; Mehibel M
Mol Pharm; 2019 Jun; 16(6):2481-2493. PubMed ID: 31013093
[TBL] [Abstract][Full Text] [Related]
13. Distinct kinetic and molecular requirements govern CD44 binding to hyaluronan versus fibrin(ogen).
Raman PS; Alves CS; Wirtz D; Konstantopoulos K
Biophys J; 2012 Aug; 103(3):415-423. PubMed ID: 22947857
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells.
Song JM; Im J; Nho RS; Han YH; Upadhyaya P; Kassie F
Mol Carcinog; 2019 Mar; 58(3):321-333. PubMed ID: 30365189
[TBL] [Abstract][Full Text] [Related]
15. Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset.
Veiseh M; Kwon DH; Borowsky AD; Tolg C; Leong HS; Lewis JD; Turley EA; Bissell MJ
Proc Natl Acad Sci U S A; 2014 Apr; 111(17):E1731-9. PubMed ID: 24733940
[TBL] [Abstract][Full Text] [Related]
16. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.
Karousou E; Misra S; Ghatak S; Dobra K; Götte M; Vigetti D; Passi A; Karamanos NK; Skandalis SS
Matrix Biol; 2017 May; 59():3-22. PubMed ID: 27746219
[TBL] [Abstract][Full Text] [Related]
17. CD44s adhesive function spontaneous and PMA-inducible CD44 cleavage are regulated at post-translational level in cells of melanocytic lineage.
Gasbarri A; Del Prete F; Girnita L; Martegani MP; Natali PG; Bartolazzi A
Melanoma Res; 2003 Aug; 13(4):325-37. PubMed ID: 12883358
[TBL] [Abstract][Full Text] [Related]
18. Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells.
Harada N; Mizoi T; Kinouchi M; Hoshi K; Ishii S; Shiiba K; Sasaki I; Matsuno S
Int J Cancer; 2001 Jan; 91(1):67-75. PubMed ID: 11149422
[TBL] [Abstract][Full Text] [Related]
19. Two novel functions of hyaluronidase-2 (Hyal2) are formation of the glycocalyx and control of CD44-ERM interactions.
Duterme C; Mertens-Strijthagen J; Tammi M; Flamion B
J Biol Chem; 2009 Nov; 284(48):33495-508. PubMed ID: 19783662
[TBL] [Abstract][Full Text] [Related]
20. CD147 mediates the CD44s-dependent differentiation of myofibroblasts driven by transforming growth factor-β
Woods EL; Grigorieva IV; Midgley AC; Brown CVM; Lu YA; Phillips AO; Bowen T; Meran S; Steadman R
J Biol Chem; 2021 Sep; 297(3):100987. PubMed ID: 34364871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
